Ann-Mari Svennerholm

Articles in Scholarly Journals [Incomplete List]

  1. Mutations in the periplasmic chaperone leading to loss of surface expression of the colonization factor CS6 in enterotoxigenic Escherichia coli (ETEC) clinical isolates
    Microbial Pathogenesis, vol. 44, no. 3, pp. 246–254, 2008
  2. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae
    Vaccine, vol. 26, no. 6, pp. 743–752, 2008
  3. Enterotoxigenic Escherichia coli is detectable in water samples from an endemic area by real-time PCR
    Journal of Applied Microbiology, vol. 104, no. 4, pp. 1128–1136, 2008
  4. Progress in vaccine development against Helicobacter pylori
    FEMS Immunology & Medical Microbiology, vol. 50, no. 2, pp. 146–156, 2007
  5. Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in Bangladesh
    Infection and Immunity, vol. 75, no. 8, pp. 3961–3968, 2007
  6. Mucosal and Systemic Immune Responses in Patients with Diarrhea Due to CS6-Expressing Enterotoxigenic Escherichia coli
    Infection and Immunity, vol. 75, no. 5, pp. 2269–2274, 2007
  7. Characterization of enterotoxigenic Escherichia coli from diarrhoeal patients in Bangladesh using phenotyping and genetic profiling
    Journal of Medical Microbiology, vol. 56, no. 2, pp. 217–222, 2007
  8. Comparative Analyses of Phenotypic and Genotypic Methods for Detection of Enterotoxigenic Escherichia coli Toxins and Colonization Factors
    Journal of Clinical Microbiology, vol. 45, no. 10, pp. 3295–3301, 2007
  9. Comparison of enterotoxigenic Escherichia coli isolated from surface water and diarrhoeal stool samples in Bangladesh
    Canadian Journal of Microbiology, vol. 53, no. 1, pp. 19–26, 2007
  10. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses
    Vaccine, vol. 25, no. 14, pp. 2591–2598, 2007
  11. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and Mexico
    Vaccine, vol. 25, no. 22, pp. 4392–4400, 2007
  12. The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10
    Clinical Immunology, vol. 125, no. 2, pp. 205–213, 2007
  13. Enterotoxigenic Escherichia coli colonization factor types collected from 1997 to 2001 in US military personnel during operation Bright Star in northern Egyptâ??â??â??
    Diagnostic Microbiology and Infectious Disease, vol. 55, no. 1, pp. 9–12, 2006
  14. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice
    Microbes and Infection, vol. 8, no. 2, pp. 442–449, 2006
  15. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3β) after exposure to Helicobacter pylori
    Microbes and Infection, vol. 8, no. 3, pp. 841–850, 2006
  16. In vivo expression of the heat stable (estA) and heat labile (eltB) toxin genes of enterotoxigenic Escherichia coli (ETEC)
    Microbes and Infection, vol. 8, no. 12-13, pp. 2797–2802, 2006
  17. Differential mechanisms for T lymphocyte recruitment in normal and neoplastic human gastric mucosa
    Clinical Immunology, vol. 118, no. 1, pp. 24–34, 2006
  18. B cells pulsed with Helicobacter pylori antigen efficiently activate memory CD8+ T cells from H. pylori-infected individuals
    Clinical Immunology, vol. 118, no. 2-3, pp. 284–291, 2006
  19. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6â??17 months of age: Dosing studies in different age groups
    Vaccine, vol. 24, no. 10, pp. 1726–1733, 2006
  20. Enterotoxigenic Escherichia coli with STh and STp Genotypes Is Associated with Diarrhea Both in Children in Areas of Endemicity and in Travelers
    Journal of Clinical Microbiology, vol. 44, no. 11, pp. 3872–3877, 2006
  21. Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in Bangladesh
    Journal of Clinical Microbiology, vol. 44, no. 11, pp. 4211–4213, 2006
  22. HpaA Is Essential for Helicobacter pylori Colonization in Mice
    Infection and Immunity, vol. 74, no. 2, pp. 920–926, 2006
  23. Journal of Proteome Research, vol. 5, no. 11, pp. 3197–3204, 2006
  24. The Major Subunit, CfaB, of Colonization Factor Antigen I from Enterotoxigenic Escherichia coli Is a Glycosphingolipid Binding Protein
    Infection and Immunity, vol. 74, no. 6, pp. 3488–3497, 2006
  25. Homologous and Cross-Reactive Immune Responses to Enterotoxigenic Escherichia coli Colonization Factors in Bangladeshi Children
    Infection and Immunity, vol. 74, no. 8, pp. 4512–4518, 2006
  26. Breast Milk Reduces the Risk of Illness in Children of Mothers With Cholera
    The Pediatric Infectious Disease Journal, vol. 25, no. 12, pp. 1163–1166, 2006
  27. Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
    Clinical Microbiology Reviews, vol. 18, no. 3, pp. 465–483, 2005
  28. Down-regulation of epithelial IL-8 responses in Helicobacter pylori-infected duodenal ulcer patients depends on host factors, rather than bacterial factors
    Clinical and Experimental Immunology, vol. 140, no. 1, pp. 117–125, 2005
  29. Serologic Correlates of Protection against Enterotoxigenic Escherichia coli Diarrhea
    The Journal of Infectious Diseases, vol. 191, no. 4, pp. 562–570, 2005
  30. Mucosal FOXP3-Expressing CD4+ CD25high Regulatory T Cells in Helicobacter pylori-Infected Patients
    Infection and Immunity, vol. 73, no. 1, pp. 523–531, 2005
  31. Reduction in Capsular Content and Enhanced Bacterial Susceptibility to Serum Killing of Vibrio cholerae O139 Associated with the 2002 Cholera Epidemic in Bangladesh
    Infection and Immunity, vol. 73, no. 10, pp. 6577–6583, 2005
  32. Natural Killer Cells and Helicobacter pylori Infection: Bacterial Antigens and Interleukin-12 Act Synergistically To Induce Gamma Interferon Production
    Infection and Immunity, vol. 73, no. 3, pp. 1482–1490, 2005
  33. Helicobacter pylori-Specific CD4+ T Cells Home to and Accumulate in the Human Helicobacter pylori-Infected Gastric Mucosa
    Infection and Immunity, vol. 73, no. 9, pp. 5612–5619, 2005
  34. Enterotoxigenic Escherichia coli Isolated from Surface Water in Urban and Rural Areas of Bangladesh
    Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3582–3583, 2005
  35. induce neutrophil transendothelial migration: Role of the bacterial HP-NAP
    FEMS Microbiology Letters, vol. 249, no. 1, pp. 95–103, 2005
  36. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
    Immunology Letters, vol. 97, no. 2, pp. 181–188, 2005
  37. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach
    Vaccine, vol. 22, no. 8, pp. 984–990, 2004
  38. Progress in enteric vaccine development
    Best Practice & Research Clinical Gastroenterology, vol. 18, no. 2, pp. 421–445, 2004
  39. Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut
    Gut, vol. 53, no. 1, pp. 62–69, 2004
  40. Phenotypic Profiles of Enterotoxigenic Escherichia coli Associated with Early Childhood Diarrhea in Rural Egypt
    Journal of Clinical Microbiology, vol. 42, no. 12, pp. 5588–5595, 2004
  41. Detection of Antibodies to Toxin-Coregulated Pili in Sera from Cholera Patients
    Infection and Immunity, vol. 72, no. 3, pp. 1824–1827, 2004
  42. Development of Pathogenicity-Driven Definitions of Outcomes for a Field Trial of a Killed Oral Vaccine against Enterotoxigenic Escherichia coli in Egypt: Application of an Evidence-Based Method
    The Journal of Infectious Diseases, vol. 189, no. 12, pp. 2299–2307, 2004
  43. Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice
    Clinical and Experimental Immunology, vol. 132, no. 3, pp. 393–400, 2003
  44. Helicobacter pylori- inflammation, immunity and vaccines
    Helicobacter, vol. 8, no. s1, pp. 31–35, 2003
  45. Decreased Epithelial Cytokine Responses in the Duodenal Mucosa of Helicobacter pylori-Infected Duodenal Ulcer Patients
    Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 1, pp. 116–124, 2003
  46. T- and B-Cell Immune Responses of Patients Who Had Undergone Colectomies to Oral Administration of Salmonella enterica Serovar Typhi Ty21a Vaccine
    Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 3, pp. 426–430, 2003
  47. Helicobacterpylori-Specific CD4+ CD25high Regulatory T Cells Suppress Memory T-Cell Responses to H. pylori in Infected Individuals
    Infection and Immunity, vol. 71, no. 4, pp. 1755–1762, 2003
  48. High Disease Burden of Diarrhea Due to Enterotoxigenic Escherichia coli among Rural Egyptian Infants and Young Children
    Journal of Clinical Microbiology, vol. 41, no. 10, pp. 4862–4864, 2003
  49. Prospects for a mucosally-administered vaccine against Helicobacter pylori
    Vaccine, vol. 21, no. 5-6, pp. 347–353, 2003
  50. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18?36 months of age
    Vaccine, vol. 21, no. 19-20, pp. 2394–2403, 2003
  51. Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum
    FEMS Immunology and Medical Microbiology, vol. 36, no. 3, pp. 159–168, 2003
  52. Priming and expression of immune responses in the gastric mucosa
    Microbes and Infection, vol. 5, no. 8, pp. 731–739, 2003
  53. Pathogenesis and host response of Helicobacter pylori
    Trends in Microbiology, vol. 10, no. 12, pp. 545–547, 2002
  54. Oral Immunization with a Salmonella enterica Serovar Typhi Vaccine Induces Specific Circulating Mucosa-Homing CD4+ and CD8+ T Cells in Humans
    Infection and Immunity, vol. 70, no. 10, pp. 5622–5627, 2002
  55. Protection against Experimental Helicobacter pylori Infection after Immunization with Inactivated H. pylori Whole-Cell Vaccines
    Infection and Immunity, vol. 70, no. 11, pp. 6383–6388, 2002
  56. Helicobacter pylori-Induced Activation of Human Endothelial Cells
    Infection and Immunity, vol. 70, no. 8, pp. 4581–4590, 2002
  57. Effects of Oral Vaccination and Immunomodulation by Cholera Toxin on Experimental Helicobacter pylori Infection, Reinfection, and Gastritis
    Infection and Immunity, vol. 70, no. 8, pp. 4621–4627, 2002
  58. Increased Levels of Inflammatory Mediators in Children and Adults Infected with Vibrio cholerae O1 and O139
    Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 2, pp. 221–229, 2002
  59. Sensitive Microplate Assay for Detection of Bactericidal Antibodies to Vibrio cholerae O139
    Clinical and Diagnostic Laboratory Immunology, vol. 9, no. 2, pp. 383–387, 2002
  60. Antigenic variation within the subunit protein of members of the colonization factor antigen I group of fimbrial proteins in human enterotoxigenic
    International Journal of Medical Microbiology, vol. 292, no. 1, pp. 43–50, 2002
  61. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants
    The Pediatric Infectious Disease Journal, vol. 21, no. 4, pp. 322–330, 2002
  62. Induction of Chemokine and Cytokine Responses by Helicobacter pylori in Human Stomach Explants
    Scandinavian Journal of Gastroenterology, vol. 36, no. 10, pp. 1022–1029, 2001
  63. CD4+ and CD8+ T cell responses in Helicobacter pylori-infected individuals
    Clinical and Experimental Immunology, vol. 123, no. 1, pp. 81–87, 2001
  64. Dose-Dependent Circulating Immunoglobulin A Antibody-Secreting Cell and Serum Antibody Responses in Swedish Volunteers to an Oral Inactivated Enterotoxigenic Escherichia coli Vaccine
    Clinical and Diagnostic Laboratory Immunology, vol. 8, no. 2, pp. 424–428, 2001
  65. Induction of Systemic Antifimbria and Antitoxin Antibody Responses in Egyptian Children and Adults by an Oral, Killed Enterotoxigenic Escherichia coli plus Cholera Toxin B Subunit Vaccine
    Infection and Immunity, vol. 69, no. 5, pp. 2853–2857, 2001
  66. Induction and Distribution of Intestinal Immune Responses after Administration of Recombinant Cholera Toxin B Subunit in the Ileal Pouches of Colectomized Patients
    Infection and Immunity, vol. 69, no. 5, pp. 3466–3471, 2001
  67. Helicobacter pylori Lipopolysaccharides Preferentially Induce CXC Chemokine Production in Human Monocytes
    Infection and Immunity, vol. 69, no. 6, pp. 3800–3808, 2001
  68. Human gastric B cell responses can be induced by intestinal immunisation
    Gut, vol. 49, no. 4, pp. 512–518, 2001
  69. Safety and Immunogenicity of Two Different Lots of the Oral, Killed Enterotoxigenic Escherichia coli-Cholera Toxin B Subunit Vaccine in Israeli Young Adults
    Infection and Immunity, vol. 68, no. 8, pp. 4492–4497, 2000
  70. Different Helicobacter pylori Strains Colonize the Antral and Duodenal Mucosa of Duodenal Ulcer Patients
    Helicobacter, vol. 5, no. 2, pp. 69–78, 2000
  71. Conceivable mechanisms by which Helicobacter pylori provokes duodenal ulcer disease
    Best Practice & Research Clinical Gastroenterology, vol. 14, no. 1, pp. 1–12, 2000
  72. Characterization of Enterotoxigenic [ITAL]Escherichia coli[/ITAL] Strains in Patients with Travelers' Diarrhea Acquired in Guadalajara, Mexico, 1992–1997
    The Journal of Infectious Diseases, vol. 181, no. 2, pp. 779–782, 2000
  73. Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children
    Vaccine, vol. 18, no. 24, pp. 2704–2712, 2000
  74. Development of a new method for the determination of immune responses in the human stomach
    Journal of Immunological Methods, vol. 234, no. 1-2, pp. 51–59, 2000
  75. Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcersâ??, â??â??
    Gastroenterology, vol. 116, no. 2, pp. 259–268, 1999
  76. Oral, Inactivated, Whole Cell Enterotoxigenic [ITAL]Escherichia coli[/ITAL] plus Cholera Toxin B Subunit Vaccine: Results of the Initial Evaluation in Children
    The Journal of Infectious Diseases, vol. 179, no. 1, pp. 107–114, 1999
  77. Differences Among Helicobacter pylori Strains Isolated from Three Different Populations and Demonstrated by Restriction Enzyme Analysis of an Internal Fragment of the Conserved Gene hpaA
    Helicobacter, vol. 4, no. 2, pp. 82–88, 1999
  78. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination.
    Journal of Clinical Investigation, vol. 102, no. 1, pp. 51–56, 1998
  79. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine
    Vaccine, vol. 16, no. 2-3, pp. 255–260, 1998
  80. Local and systemic immune responses in humans againstHelicobacter pyloriantigens from homologous and heterologous strains
    Microbial Pathogenesis, vol. 23, no. 5, pp. 285–296, 1997
  81. Binding of enterotoxigenicEscherichia colito isolated enterocytes and intestinal mucus
    Microbial Pathogenesis, vol. 23, no. 6, pp. 335–346, 1997
  82. Digestive Diseases and Sciences, vol. 42, no. 3, pp. 554–567, 1997
  83. Monoclonal antibodies against fimbrial subunits of colonization factor antigen I (CFA/I) inhibit binding to human enterocytes and protect against enterotoxigenicEscherichia coliexpressing heterologous colonization factors
    Microbial Pathogenesis, vol. 21, no. 1, pp. 35–45, 1996
  84. Binding of enterotoxigenicEscherichia coliexpressing different colonization factors to tissue-cultured Caco-2 cells and to isolated human enterocytes
    Microbial Pathogenesis, vol. 21, no. 2, pp. 139–147, 1996
  85. Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up
    Vaccine, vol. 14, no. 2, pp. 162–166, 1996
  86. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine
    Vaccine, vol. 14, no. 15, pp. 1459–1465, 1996
  87. Colonization factors of human enterotoxigenic Escherichia coli (ETEC)
    Trends in Microbiology, vol. 4, no. 11, pp. 444–452, 1996
  88. Optimization of the intestinal lavage procedure for determination of intestinal immune responses
    Vaccine, vol. 13, no. 18, pp. 1754–1758, 1995
  89. Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru
    Vaccine, vol. 13, no. 7, pp. 691–694, 1995
  90. Adhesins ofEscherichia coliassociated with extra–intestinal pathogenicity confer binding to colonic epithelial cells
    Microbial Pathogenesis, vol. 18, no. 6, pp. 373–385, 1995
  91. Immunological response to Vibrio cholerae O1 infection and an oral cholera vaccine among Peruvians
    Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 5, pp. 542–545, 1995
  92. Gastric Output of IgA in Man: Relation to Migrating Motility Complexes and Sham Feeding
    Scandinavian Journal of Gastroenterology, vol. 30, no. 7, pp. 657–663, 1995
  93. A Simple, Rapid, and Highly Reliable Capsule-based 14C Urea Breath Test for Diagnosis of Helicobacter pylori Infection
    Scandinavian Journal of Gastroenterology, vol. 30, no. 11, pp. 1058–1063, 1995
  94. Campylobacter jejuni/coli and Enterotoxigenic Eschericia coli (ETEC) in Faeces from Children and Adults in Tanzania
    Scandinavian Journal of Infectious Diseases, vol. 27, no. 6, pp. 589–593, 1995
  95. Colonization factor antigens (CFAs) of enterotoxigenic Escherichia coli can prime and boost immune responses against heterologous CFAs
    Microbial Pathogenesis, vol. 16, no. 2, pp. 131–139, 1994
  96. Immunological memory after immunization with oral cholera B subunit-whole-cell vaccine in Swedish volunteers
    Vaccine, vol. 12, no. 12, pp. 1078–1082, 1994
  97. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits
    The Lancet, vol. 344, no. 8932, pp. 1273–1276, 1994
  98. Induction of colonization factor antigen I (CFA/I) and coli surface antigen 4 (CS4) of enterotoxigenic Escherichia coli: relevance for vaccine production
    Vaccine, vol. 11, no. 2, pp. 221–226, 1993
  99. Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers
    Vaccine, vol. 11, no. 10, pp. 1007–1012, 1993
  100. Intestinal antibody response after oral immunization with a prototype cholera B subunit ? colonization factor antigen enterotoxigenic Escherichia coli vaccine
    Vaccine, vol. 11, no. 9, pp. 929–934, 1993
  101. Safety and immunogenicity of an oral recombinant cholera B subunit—whole cell vaccine in Swedish volunteers
    Vaccine, vol. 10, no. 2, pp. 130–132, 1992
  102. An oral B subunit: whole cell vaccine against cholera
    Vaccine, vol. 10, no. 13, pp. 911–914, 1992
  103. T and B cell responses to chimeric proteins containing heterologous T helper epitopes inserted at different positions*1
    Molecular Immunology, vol. 29, no. 10, pp. 1185–1190, 1992
  104. Inhibited growth of common enteropathogenic bacteria in lactic-fermented cereal gruels
    World Journal of Microbiology & Biotechnology, vol. 8, no. 6, pp. 601–606, 1992
  105. Roles of different putative colonization factor antigens in colonization of human enterotoxigenic Escherichia coli in rabbits
    Microbial Pathogenesis, vol. 13, no. 5, pp. 381–389, 1992
  106. Presence of cfaD-homologous sequences and expression of coli surface antigen 4 on enterotoxigenic Escherichia coli; relevance for diagnostic procedures
    Microbial Pathogenesis, vol. 11, no. 4, pp. 297–304, 1991
  107. Identification of a mannose-binding pilus on Vibrio cholerae El Tor
    Microbial Pathogenesis, vol. 11, no. 6, pp. 433–441, 1991
  108. Epitope differences in toxin-coregulated pili produced by classical and El Tor Vibrio cholerae O1
    Microbial Pathogenesis, vol. 11, no. 3, pp. 179–188, 1991
  109. Biotype as determinant of natural immunising effect of cholera
    The Lancet, vol. 337, no. 8746, pp. 883–884, 1991
  110. Determination of K88 antigens and enterotoxins of Escherichia coli strains isolated from Polish piglets with diarrhea by the use of enzyme-linked immunosorbent assays
    Veterinary Microbiology, vol. 29, no. 3-4, pp. 299–307, 1991
  111. Enterotoxin-producing bacteria isolated from swedish travellers with diarrhoea
    Scandinavian Journal of Infectious Diseases, vol. 23, no. 4, pp. 473–479, 1991
  112. Serum Antibody Responses to Bacterial Enteropathogens in Swedish Travellers to South-East Asia
    Scandinavian Journal of Infectious Diseases, vol. 22, no. 6, pp. 699–704, 1990
  113. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines
    Vaccine, vol. 8, no. 5, pp. 469–472, 1990
  114. Identification of asialo GM1 as a binding structure for Escherichia coli colonization factor antigens
    FEMS Microbiology Letters, vol. 72, no. 3, pp. 289–292, 1990
  115. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up
    The Lancet, vol. 335, no. 8684, pp. 270–273, 1990
  116. Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T helper epitope
    European Journal of Immunology, vol. 20, no. 7, pp. 1541–1545, 1990
  117. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination
    Research in Microbiology, vol. 141, no. 7-8, pp. 971–979, 1990
  118. New cholera vaccines
    Vaccine, vol. 7, no. 2, pp. 94–96, 1989
  119. Oral cholera vaccines containing B-subunit—killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family
    Vaccine, vol. 7, no. 2, pp. 117–120, 1989
  120. Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea
    Vaccine, vol. 7, no. 3, pp. 196–198, 1989
  121. The maltose-inducible 43 kDa major outer membrane protein in Vibrio cholerae is immunogenic and common to different isolates
    Microbial Pathogenesis, vol. 5, no. 3, pp. 169–175, 1988
  122. Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit
    FEBS Letters, vol. 241, no. 1-2, pp. 110–114, 1988
  123. IMPACT OF B SUBUNIT KILLED WHOLE-CELL AND KILLED WHOLE-CELL-ONLY ORAL VACCINES AGAINST CHOLERA UPON TREATED DIARRHOEAL ILLNESS AND MORTALITY IN AN AREA ENDEMIC FOR CHOLERA
    The Lancet, vol. 331, no. 8599, pp. 1375–1379, 1988
  124. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection
    Microbial Pathogenesis, vol. 1, no. 4, pp. 361–371, 1986
  125. Serological subtypes ofEscherichia coli colonization factor antigen II
    European Journal of Clinical Microbiology, vol. 1, no. 2, pp. 107–111, 1982
  126. INTESTINAL ANTIBODY RESPONSES AFTER IMMUNISATION WITH CHOLERA B SUBUNIT
    The Lancet, vol. 319, no. 8267, pp. 305–308, 1982
  127. Isolation ofEscherichia coli heat-labile enterotoxin by affinity chromatography: Characterization of subunits
    Current Microbiology, vol. 3, no. 6, pp. 339–344, 1980
  128. Immunological cross-reactivity betweenEscherichia coli heat-labile enterotoxin and cholera toxin A and B subunits
    Current Microbiology, vol. 2, no. 1, pp. 55–58, 1979
  129. Identification ofEscherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure
    Current Microbiology, vol. 1, no. 1, pp. 19–23, 1978
  130. Development of improved cholera vaccine based on subunit toxoid
    Nature, vol. 269, no. 5629, Article ID 269602a0, 2 pages, 1977
  131. A Radial Diffusion Agar Plaque Technique for Estimation of the Avidity of Bactericidal Antibodies against Vibrio cholerae
    Scandinavian Journal of Immunology, vol. 1, no. 4, pp. 345–350, 1972
  132. Antibodies to endotoxin from Vibrio cholerae measured by bactericidal and indirect hemagglutination tests. Differences in immunoglobulin classes and specificity
    Journal of Immunological Methods, vol. 1, no. 4, pp. 329–340, 1972